
An unusual long-term outcome of a child with primary myelofibrosis harboring a JAK2 mutation
Keywords: BM; bone marrow; MPN; myeloproliferative neoplasm; CMD; chronic myeloproliferative disease; DIPSS; dynamic-IPSS; EC; endothelial cells; HSCT; hematopoietic stem cell transplantation; INCA; Instituto Nacional de Câncer; IPSS; International Prognostic Scor